News

AddToAny

Google+ Facebook Twitter Twitter

Early results for gene editing study

Early, partial results from a historic gene editing study indicate that the treatment may be safe and having at least some of its hoped-for effect.

However, it is too soon to know whether it will ultimately succeed.

The results, announced in September, are from the first human test of gene editing in the body – an attempt to permanently change someone’s DNA to cure a disease.

In this case, they are tackling a genetic disorder called Hunter syndrome that often kills people in their teens. In two patients who got a medium dose of the treatment, urine levels of large sugar compounds that are hallmarks of Hunter syndrome had fallen by half, on average, four months later – a possible sign the treatment is working.

Two others who got a low dose have seen little change in these sugars so far.

However, there’s no way to know yet whether the change are due to the gene editing.

Related Articles

Embedding genomics in the NHS

Genomics England is beginning a dialogue to explore public aspirations, concerns and expectations about the development of genomics and genomic medicine in the UK.

Personalised pathology solutions

CliniSys’ Pathology Relationship Management (PRM) solution has been specifically designed to support healthcare professionals and the business of pathology.

Journal-based learning: iStock

Journal-based learning exercises - October 2018

Each article’s contents should be read, researched and understood, and you should then come to a decision on each question. The pass mark is 17 out of 20 questions answered correctly. JBL exercises may be completed at any time until the published deadline date. Please select your choice of correct answers and complete the exercises online at: www.ibms.org/cpd/jbl

Download PDF

National Pathology Week

The IBMS is encouraging member’s to get involved in National Pathology Week, which takes place next month.

Top